SLC40A1 and Sepsis: However, in our study, treatment with β-glucan, SPIO, or combined β-glucan and SPIO protected FPN1-deficient mice against sepsis, manifested by reduced blood bacterial burden and lung damage (Supplementary Figure S7B-E).